Article
Comprehensive analysis of high-throughput transcriptomics to distinguish drug-induced liver injury (DILI) phenotypes.
Archives of toxicology - 1 Sept 2025
Shin Sangyeon, Lee Chanhee, Park Taesung
Abstract excerpt
Drug-Induced Liver Injury (DILI) is a major challenge in drug development, occurring due to liver damage caused by the adverse effects of drugs or xenobiotics. High-throughput transcriptomics (HTTr) provides mechanistic insights into drug-induced hepatotoxicity, complementing traditional chemical structure-based methods. To address the challenges posed by DILI, this study aimed to evaluate the suitability of HTTr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
